SUPPLEMENTARY TABLE 3. Gene Ranking: 277 Deregulated Genes

Total Page:16

File Type:pdf, Size:1020Kb

SUPPLEMENTARY TABLE 3. Gene Ranking: 277 Deregulated Genes SUPPLEMENTARY TABLE 3. Gene ranking: 277 deregulated genes. overexpressed in the sequence NCF/CAF-PT/CAF-LM mean Log2 normalised expression Fold changes Probe ID gene symbol NCF CAF-PT CAF-LM CAF-PT/NCF CAF-LM/CAF-PT pval qval Gene_description 8114970 C5orf46 4.721 5.843 9.288 1.773 14.845 4.22E-05 0 chromosome 5 open reading frame 46 8130173 RAET1L 7.421 8.139 8.923 1.667 1.665 4.22E-05 0 retinoic acid early transcript 1L 7898413 PADI1 6.316 6.989 7.628 1.535 1.590 4.22E-05 0 peptidyl arginine deiminase, type I 8020455 GATA6 7.902 8.665 9.846 1.598 2.751 4.22E-05 0 GATA binding protein 6 8058450 GPR1 5.420 6.989 8.559 2.921 3.498 4.22E-05 0 G protein-coupled receptor 1 8111387 ADAMTS12 8.507 9.214 10.544 1.663 2.451 4.22E-05 0 ADAM metallopeptidase with thrombospondin type 1 motif, 12 8100382 CHIC2 8.343 9.081 10.723 1.616 3.392 4.22E-05 0 cysteine-rich hydrophobic domain 2 7938485 MICAL2 9.309 10.477 11.568 2.320 2.180 4.22E-05 0 microtubule associated monoxygenase, calponin and LIM domain containing 2 7909789 TGFB2 8.478 10.294 11.406 4.254 1.710 4.22E-05 0 transforming growth factor, beta 2 7953284 NTF3 7.510 8.920 9.474 2.429 1.601 4.22E-05 0 neurotrophin 3 8110932 SEMA5A 8.892 10.081 11.490 2.956 2.526 4.22E-05 0 semaphorin 5A 8122720 ULBP2 6.024 7.831 8.695 3.896 1.531 4.22E-05 0 UL16 binding protein 2 7945245 NTM 7.702 9.005 10.360 1.976 2.891 4.22E-05 0 neurotrimin 8020878 MAPRE2 9.217 9.644 11.028 1.508 2.648 4.22E-05 0 microtubule-associated protein, RP/EB family, member 2 8112007 EMB 4.721 5.986 7.610 1.941 4.055 4.22E-05 0 embigin homolog (mouse) 8114805 FGF1 8.285 8.947 10.377 1.642 2.564 4.22E-05 0 fibroblast growth factor 1 (acidic) 7997504 CDH13 9.137 10.213 11.836 1.624 3.521 4.22E-05 0 cadherin 13, H-cadherin (heart) 7942957 PRSS23 10.003 10.624 11.361 1.725 1.669 4.22E-05 0 protease, serine, 23 8126798 GPR116 5.713 6.832 8.788 1.513 6.179 4.22E-05 0 G protein-coupled receptor 116 8091283 PLOD2 10.341 11.115 11.905 1.829 1.628 4.22E-05 0 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 8083594 PTX3 6.636 7.384 9.315 1.658 3.914 4.22E-05 0 pentraxin-related gene, rapidly induced by IL-1 beta 8112615 ENC1 7.499 8.736 10.119 1.919 3.319 4.22E-05 0 ectodermal-neural cortex (with BTB-like domain) 8075910 RAC2 7.750 8.344 9.316 1.586 1.956 4.22E-05 0 ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) 7961532 ARHGDIB 6.378 7.014 10.357 1.687 10.129 4.22E-05 0 Rho GDP dissociation inhibitor (GDI) beta 7922337 TNFSF18 5.058 5.952 7.299 1.551 2.594 4.22E-05 0 tumor necrosis factor (ligand) superfamily, member 18 7912520 NPPB 7.430 8.786 11.781 1.951 21.345 4.22E-05 0 natriuretic peptide precursor B 8022674 CDH2 8.433 9.500 11.151 2.314 3.324 4.22E-05 0 cadherin 2, type 1, N-cadherin (neuronal) 8135069 SERPINE1 10.674 11.720 13.061 2.414 2.124 4.22E-05 0 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 8104022 PDLIM3 7.661 9.312 10.736 3.207 3.096 4.22E-05 0 PDZ and LIM domain 3 8144786 SLC7A2 6.311 7.254 9.480 2.127 5.056 4.22E-05 0 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 7965094 E2F7 7.265 8.284 9.435 1.793 2.534 4.22E-05 0 E2F transcription factor 7 8108905 KCTD16 7.252 8.329 9.164 2.206 1.815 4.22E-05 0 potassium channel tetramerisation domain containing 16 7990054 UACA 7.406 8.688 11.202 2.204 7.039 4.22E-05 0 uveal autoantigen with coiled-coil domains and ankyrin repeats 8081219 ST3GAL6 6.097 6.795 7.875 1.836 2.220 4.22E-05 0 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 7955637 KRT18 9.486 10.448 11.824 2.563 2.516 4.22E-05 0 keratin 18 8102831 C4orf49 9.015 10.000 11.522 2.078 3.194 4.22E-05 0 chromosome 4 open reading frame 49 8163149 PTPN3 6.790 7.252 8.034 1.551 1.557 4.22E-05 0 protein tyrosine phosphatase, non-receptor type 3 8006736 DUSP14 9.066 9.541 10.164 1.590 1.510 4.22E-05 0 dual specificity phosphatase 14 8077441 BHLHE40 9.092 9.735 10.862 1.988 2.030 4.22E-05 0 basic helix-loop-helix family, member e40 7942941 CCDC81 6.520 7.211 9.082 1.528 4.529 4.23E-05 0 coiled-coil domain containing 81 8058849 MARCH4 8.489 9.367 9.981 2.000 1.598 4.23E-05 0 membrane-associated ring finger (C3HC4) 4 7934979 ANKRD1 6.930 8.770 11.579 4.973 7.189 4.23E-05 0 ankyrin repeat domain 1 (cardiac muscle) 8107673 GRAMD3 9.299 10.131 11.070 1.824 1.929 4.23E-05 0 GRAM domain containing 3 8130674 PDE10A 7.184 7.675 8.920 1.724 2.311 4.23E-05 0 phosphodiesterase 10A 8140534 SEMA3C 8.333 9.010 10.736 1.795 3.222 4.23E-05 0 sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C 7927964 SRGN 7.730 8.652 12.309 1.830 17.546 4.23E-05 0 serglycin 8097058 CEP170L 6.689 7.465 8.384 1.591 1.827 4.24E-05 0 centrosomal protein 170kDa-like 8149574 CSGALNACT1 6.226 6.956 8.307 1.519 2.838 4.24E-05 0 chondroitin sulfate N-acetylgalactosaminyltransferase 1 8103630 SH3RF1 8.949 9.557 10.397 1.564 1.763 4.25E-05 0 SH3 domain containing ring finger 1 7995838 MT1X 8.504 9.170 10.824 1.550 2.897 4.25E-05 0 metallothionein 1X 8139207 INHBA 10.513 11.390 12.265 1.939 1.824 4.26E-05 0 inhibin, beta A 7922343 TNFSF4 5.800 8.691 10.041 9.118 2.465 4.28E-05 0 tumor necrosis factor (ligand) superfamily, member 4 7922807 GLT25D2 6.545 7.324 8.141 2.091 1.868 4.28E-05 0 glycosyltransferase 25 domain containing 2 7964733 RPSAP52 4.814 5.687 7.396 1.943 4.516 4.29E-05 0 ribosomal protein SA pseudogene 52 8057898 HECW2 7.069 7.389 9.173 1.532 2.827 4.30E-05 0 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 8154245 PDCD1LG2 9.131 9.834 10.982 1.623 2.198 4.32E-05 0 programmed cell death 1 ligand 2 8139087 SFRP4 6.370 6.677 9.818 1.771 9.160 4.34E-05 0 secreted frizzled-related protein 4 8109830 CCDC99 7.865 8.597 9.604 1.603 2.189 4.43E-05 0 coiled-coil domain containing 99 7983478 C15orf48 6.224 7.293 9.997 2.059 11.537 4.44E-05 0 chromosome 15 open reading frame 48 8007363 WNK4 7.332 8.488 9.390 2.507 1.811 4.45E-05 0 WNK lysine deficient protein kinase 4 8056491 SCN9A 8.756 9.567 10.418 1.915 1.886 4.67E-05 0 sodium channel, voltage-gated, type IX, alpha subunit 7995697 LPCAT2 7.923 8.676 9.327 1.557 1.650 4.80E-05 0 lysophosphatidylcholine acyltransferase 2 7975459 SIPA1L1 9.643 10.214 10.703 1.504 1.549 4.92E-05 0 signal-induced proliferation-associated 1 like 1 8149749 TNFRSF10D 9.306 9.921 10.559 1.518 1.641 5.09E-05 0 tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain 7962212 PKP2 7.166 8.248 9.109 2.453 1.689 5.13E-05 0 plakophilin 2 8078529 STAC 5.682 6.424 7.998 1.932 2.874 5.14E-05 0 SH3 and cysteine rich domain 7995797 MT1E 8.076 8.603 11.006 1.995 5.331 5.15E-05 0 metallothionein 1E 7976012 NRXN3 7.610 9.305 10.582 5.443 1.909 5.36E-05 0 neurexin 3 8085138 OXTR 8.975 9.877 10.647 1.922 1.860 5.93E-05 0 oxytocin receptor 7906919 RGS4 7.442 8.834 10.929 1.803 7.067 6.34E-05 0 regulator of G-protein signaling 4 7972750 COL4A1 10.058 10.646 11.258 1.510 1.536 6.37E-05 0 collagen, type IV, alpha 1 8120654 KCNQ5 6.591 7.502 8.119 1.860 1.745 6.96E-05 0 potassium voltage-gated channel, KQT-like subfamily, member 5 7918869 NGF 8.711 9.270 10.270 1.584 2.044 8.15E-05 0 nerve growth factor (beta polypeptide) 7963567 KRT8 7.958 9.015 9.665 1.714 2.181 8.95E-05 0 keratin 8 8098006 GLRB 6.240 6.880 7.250 1.647 1.506 9.21E-05 0 glycine receptor, beta 8177732 HLA-A 9.001 9.928 10.572 1.640 1.777 9.73E-05 0 major histocompatibility complex, class I, A 7909503 SERTAD4 5.565 6.616 7.365 2.557 1.556 1.01E-04 0 SERTA domain containing 4 7984259 RNU5B-1 5.061 6.371 7.402 1.580 5.525 1.16E-04 0 RNA, U5B small nuclear 1 8054479 MALL 7.714 8.847 9.245 1.940 1.654 1.52E-04 0 mal, T-cell differentiation protein-like 7946983 SAA2 7.550 9.144 10.278 2.910 2.545 1.68E-04 0 serum amyloid A2 8015268 KRT34 7.660 9.128 10.109 4.600 1.551 2.58E-04 2.96E-05 keratin 34 7995793 MT1L 9.747 10.224 11.137 1.549 1.963 2.68E-04 2.96E-05 metallothionein 1L (gene/pseudogene) 8063458 DOK5 7.566 8.253 9.540 2.092 2.492 3.54E-04 2.96E-05 docking protein 5 8092726 CLDN1 7.804 8.688 9.540 1.870 2.406 3.63E-04 2.96E-05 claudin 1 7934570 KCNMA1 8.416 9.089 9.918 1.804 2.183 4.07E-04 2.96E-05 potassium large conductance calcium-activated channel, subfamily M, alpha member 1 8145793 SNORD13 9.170 9.982 10.912 1.693 2.595 4.60E-04 7.80E-05 small nucleolar RNA, C/D box 13 8174201 BEX1 7.443 8.478 9.762 2.133 4.555 1.82E-03 1.40E-04 brain expressed, X-linked 1 8147049 FABP5L1 7.644 8.204 9.164 1.881 1.928 2.05E-03 2.93E-04 fatty acid binding protein 5-like 1 (pseudogene) 8114572 HBEGF 8.038 8.592 9.400 1.761 1.610 2.25E-03 2.93E-04 heparin-binding EGF-like growth factor 8005955 SNORD42A 5.488 7.085 7.362 1.686 3.452 3.74E-03 5.78E-04 small nucleolar RNA, C/D box 42A 8105267 ITGA2 8.882 9.456 10.403 2.207 2.435 4.16E-03 5.78E-04 integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) 7981996 SNRPN 6.023 6.930 7.348 1.730 1.640 5.15E-03 5.78E-04 small nuclear ribonucleoprotein polypeptide N 8135218 LRRC17 7.751 8.722 9.688 1.710 2.989 5.90E-03 5.78E-04 leucine rich repeat containing 17 7971077 POSTN 7.991 9.617 10.518 3.413 3.003 1.03E-02 1.10E-03 periostin, osteoblast specific factor 7926545 PLXDC2 8.599 9.571 9.907 2.363 1.576 1.20E-02 1.99E-03 plexin domain containing 2 7990345 SEMA7A 8.578 9.107 9.576 1.630 1.740 1.24E-02 1.99E-03 semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) 8145361 NEFM 7.462 8.308 8.786 1.593 1.908 4.00E-02 5.59E-03 neurofilament, medium polypeptide 8180303 SAA2 8.081 9.114 9.758 2.134 2.315 1.05E-01 1.89E-02 serum amyloid A2 infraexpressed
Recommended publications
  • Comparative Transcriptome Analysis of Embryo Invasion in the Mink Uterus
    Placenta 75 (2019) 16–22 Contents lists available at ScienceDirect Placenta journal homepage: www.elsevier.com/locate/placenta Comparative transcriptome analysis of embryo invasion in the mink uterus T ∗ Xinyan Caoa,b, , Chao Xua,b, Yufei Zhanga,b, Haijun Weia,b, Yong Liuc, Junguo Caoa,b, Weigang Zhaoa,b, Kun Baoa,b, Qiong Wua,b a Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, China b State Key Laboratory for Molecular Biology of Special Economic Animal and Plant Science, Chinese Academy of Agricultural Sciences, Changchun, China c Key Laboratory of Embryo Development and Reproductive Regulation of Anhui Province, College of Biological and Food Engineering, Fuyang Teachers College, Fuyang, China ABSTRACT Introduction: In mink, as many as 65% of embryos die during gestation. The causes and the mechanisms of embryonic mortality remain unclear. The purpose of our study was to examine global gene expression changes during embryo invasion in mink, and thereby to identify potential signaling pathways involved in implantation failure and early pregnancy loss. Methods: Illumina's next-generation sequencing technology (RNA-Seq) was used to analyze the differentially expressed genes (DEGs) in implantation (IMs) and inter- implantation sites (inter-IMs) of uterine tissue. Results: We identified a total of 606 DEGs, including 420 up- and 186 down-regulated genes in IMs compared to inter-IMs. Gene annotation analysis indicated multiple biological pathways to be significantly enriched for DEGs, including immune response, ECM complex, cytokine activity, chemokine activity andprotein binding. The KEGG pathway including cytokine-cytokine receptor interaction, Jak-STAT, TNF and the chemokine signaling pathway were the most enriched.
    [Show full text]
  • ADAMTS13 and 15 Are Not Regulated by the Full Length and N‑Terminal Domain Forms of TIMP‑1, ‑2, ‑3 and ‑4
    BIOMEDICAL REPORTS 4: 73-78, 2016 ADAMTS13 and 15 are not regulated by the full length and N‑terminal domain forms of TIMP‑1, ‑2, ‑3 and ‑4 CENQI GUO, ANASTASIA TSIGKOU and MENG HUEE LEE Department of Biological Sciences, Xian Jiaotong-Liverpool University, Suzhou, Jiangsu 215123, P.R. China Received June 29, 2015; Accepted July 15, 2015 DOI: 10.3892/br.2015.535 Abstract. A disintegrin and metalloproteinase with thom- proteolysis activities associated with arthritis, morphogenesis, bospondin motifs (ADAMTS) 13 and 15 are secreted zinc angiogenesis and even ovulation [as reviewed previously (1,2)]. proteinases involved in the turnover of von Willebrand factor Also known as the VWF-cleaving protease, ADAMTS13 and cancer suppression. In the present study, ADAMTS13 is noted for its ability in cleaving and reducing the size of the and 15 were subjected to inhibition studies with the full-length ultra-large (UL) form of the VWF. Reduction in ADAMTS13 and N-terminal domain forms of tissue inhibitor of metallo- activity from either hereditary or acquired deficiency causes proteinases (TIMPs)-1 to -4. TIMPs have no ability to inhibit accumulation of UL-VWF multimers, platelet aggregation and the ADAMTS proteinases in the full-length or N-terminal arterial thrombosis that leads to fatal thrombotic thrombocy- domain form. While ADAMTS13 is also not sensitive to the topenic purpura [as reviewed previously (1,3)]. By contrast, hydroxamate inhibitors, batimastat and ilomastat, ADAMTS15 ADAMTS15 is a potential tumor suppressor. Only a limited app can be effectively inhibited by batimastat (Ki 299 nM). In number of in-depth investigations have been carried out on the conclusion, the present results indicate that TIMPs are not the enzyme; however, expression and profiling studies have shown regulators of these two ADAMTS proteinases.
    [Show full text]
  • ADAMTS Proteases in Vascular Biology
    Review MATBIO-1141; No. of pages: 8; 4C: 3, 6 ADAMTS proteases in vascular biology Juan Carlos Rodríguez-Manzaneque 1, Rubén Fernández-Rodríguez 1, Francisco Javier Rodríguez-Baena 1 and M. Luisa Iruela-Arispe 2 1 - GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad de Granada, Junta de Andalucía, 18016 Granada, Spain 2 - Department of Molecular, Cell, and Developmental Biology, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA Correspondence to Juan Carlos Rodríguez-Manzaneque and M. Luisa Iruela-Arispe: J.C Rodríguez-Manzaneque is to be contacted at: GENYO, 15 PTS Granada - Avda. de la Ilustración 114, Granada 18016, Spain; M.L. Iruela-Arispe, Department of Molecular, Cell and Developmental Biology, UCLA, 615 Charles Young Drive East, Los Angeles, CA 90095, USA. [email protected]; [email protected] http://dx.doi.org/10.1016/j.matbio.2015.02.004 Edited by W.C. Parks and S. Apte Abstract ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) proteases comprise the most recently discovered branch of the extracellular metalloenzymes. Research during the last 15 years, uncovered their association with a variety of physiological and pathological processes including blood coagulation, tissue repair, fertility, arthritis and cancer. Importantly, a frequent feature of ADAMTS enzymes relates to their effects on vascular-related phenomena, including angiogenesis. Their specific roles in vascular biology have been clarified by information on their expression profiles and substrate specificity. Through their catalytic activity, ADAMTS proteases modify rather than degrade extracellular proteins. They predominantly target proteoglycans and glycoproteins abundant in the basement membrane, therefore their broad contributions to the vasculature should not come as a surprise.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Pancancer Progression Human Vjune2017
    Gene Symbol Accession Alias/Prev Symbol Official Full Name AAMP NM_001087.3 - angio-associated, migratory cell protein ABI3BP NM_015429.3 NESHBP|TARSH ABI family, member 3 (NESH) binding protein ACHE NM_000665.3 ACEE|ARACHE|N-ACHE|YT acetylcholinesterase ACTG2 NM_001615.3 ACT|ACTA3|ACTE|ACTL3|ACTSG actin, gamma 2, smooth muscle, enteric ACVR1 NM_001105.2 ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI activin A receptor, type I ACVR1C NM_145259.2 ACVRLK7|ALK7 activin A receptor, type IC ACVRL1 NM_000020.1 ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I activin A receptor type II-like 1 ADAM15 NM_207195.1 MDC15 ADAM metallopeptidase domain 15 ADAM17 NM_003183.4 ADAM18|CD156B|CSVP|NISBD|TACE ADAM metallopeptidase domain 17 ADAM28 NM_014265.4 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII ADAM metallopeptidase domain 28 ADAM8 NM_001109.4 CD156|MS2 ADAM metallopeptidase domain 8 ADAM9 NM_001005845.1 CORD9|MCMP|MDC9|Mltng ADAM metallopeptidase domain 9 ADAMTS1 NM_006988.3 C3-C5|METH1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 ADAMTS12 NM_030955.2 PRO4389 ADAM metallopeptidase with thrombospondin type 1 motif, 12 ADAMTS8 NM_007037.4 ADAM-TS8|METH2 ADAM metallopeptidase with thrombospondin type 1 motif, 8 ADAP1 NM_006869.2 CENTA1|GCS1L|p42IP4 ArfGAP with dual PH domains 1 ADD1 NM_001119.4 ADDA adducin 1 (alpha) ADM2 NM_001253845.1 AM2|dJ579N16.4 adrenomedullin 2 ADRA2B NM_000682.4 ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR adrenoceptor alpha 2B AEBP1 NM_001129.3 ACLP AE binding protein 1 AGGF1 NM_018046.3 GPATC7|GPATCH7|HSU84971|HUS84971|VG5Q
    [Show full text]
  • Gene Symbol Category ACAN ECM ADAM10 ECM Remodeling-Related ADAM11 ECM Remodeling-Related ADAM12 ECM Remodeling-Related ADAM15 E
    Supplementary Material (ESI) for Integrative Biology This journal is (c) The Royal Society of Chemistry 2010 Gene symbol Category ACAN ECM ADAM10 ECM remodeling-related ADAM11 ECM remodeling-related ADAM12 ECM remodeling-related ADAM15 ECM remodeling-related ADAM17 ECM remodeling-related ADAM18 ECM remodeling-related ADAM19 ECM remodeling-related ADAM2 ECM remodeling-related ADAM20 ECM remodeling-related ADAM21 ECM remodeling-related ADAM22 ECM remodeling-related ADAM23 ECM remodeling-related ADAM28 ECM remodeling-related ADAM29 ECM remodeling-related ADAM3 ECM remodeling-related ADAM30 ECM remodeling-related ADAM5 ECM remodeling-related ADAM7 ECM remodeling-related ADAM8 ECM remodeling-related ADAM9 ECM remodeling-related ADAMTS1 ECM remodeling-related ADAMTS10 ECM remodeling-related ADAMTS12 ECM remodeling-related ADAMTS13 ECM remodeling-related ADAMTS14 ECM remodeling-related ADAMTS15 ECM remodeling-related ADAMTS16 ECM remodeling-related ADAMTS17 ECM remodeling-related ADAMTS18 ECM remodeling-related ADAMTS19 ECM remodeling-related ADAMTS2 ECM remodeling-related ADAMTS20 ECM remodeling-related ADAMTS3 ECM remodeling-related ADAMTS4 ECM remodeling-related ADAMTS5 ECM remodeling-related ADAMTS6 ECM remodeling-related ADAMTS7 ECM remodeling-related ADAMTS8 ECM remodeling-related ADAMTS9 ECM remodeling-related ADAMTSL1 ECM remodeling-related ADAMTSL2 ECM remodeling-related ADAMTSL3 ECM remodeling-related ADAMTSL4 ECM remodeling-related ADAMTSL5 ECM remodeling-related AGRIN ECM ALCAM Cell-cell adhesion ANGPT1 Soluble factors and receptors
    [Show full text]
  • Key Genes Regulating Skeletal Muscle Development and Growth in Farm Animals
    animals Review Key Genes Regulating Skeletal Muscle Development and Growth in Farm Animals Mohammadreza Mohammadabadi 1 , Farhad Bordbar 1,* , Just Jensen 2 , Min Du 3 and Wei Guo 4 1 Department of Animal Science, Faculty of Agriculture, Shahid Bahonar University of Kerman, Kerman 77951, Iran; [email protected] 2 Center for Quantitative Genetics and Genomics, Aarhus University, 8210 Aarhus, Denmark; [email protected] 3 Washington Center for Muscle Biology, Department of Animal Sciences, Washington State University, Pullman, WA 99163, USA; [email protected] 4 Muscle Biology and Animal Biologics, Animal and Dairy Science, University of Wisconsin-Madison, Madison, WI 53558, USA; [email protected] * Correspondence: [email protected] Simple Summary: Skeletal muscle mass is an important economic trait, and muscle development and growth is a crucial factor to supply enough meat for human consumption. Thus, understanding (candidate) genes regulating skeletal muscle development is crucial for understanding molecular genetic regulation of muscle growth and can be benefit the meat industry toward the goal of in- creasing meat yields. During the past years, significant progress has been made for understanding these mechanisms, and thus, we decided to write a comprehensive review covering regulators and (candidate) genes crucial for muscle development and growth in farm animals. Detection of these genes and factors increases our understanding of muscle growth and development and is a great help for breeders to satisfy demands for meat production on a global scale. Citation: Mohammadabadi, M.; Abstract: Farm-animal species play crucial roles in satisfying demands for meat on a global scale, Bordbar, F.; Jensen, J.; Du, M.; Guo, W.
    [Show full text]
  • Ultra-Processed Food Targets Bone Quality Via Endochondral Ossification
    Bone Research www.nature.com/boneres ARTICLE OPEN Ultra-processed food targets bone quality via endochondral ossification Janna Zaretsky1, Shelley Griess-Fishheimer1, Adi Carmi1, Tamara Travinsky Shmul1, Lior Ofer2, Tali Sinai1, Svetlana Penn1, Ron Shahar2 and Efrat Monsonego-Ornan 1 Ultra-processed foods have known negative implications for health; however, their effect on skeletal development has never been explored. Here, we show that young rats fed ultra-processed food rich in fat and sugar suffer from growth retardation due to lesions in their tibial growth plates. The bone mineral density decreases significantly, and the structural parameters of the bone deteriorate, presenting a sieve-like appearance in the cortices and poor trabecular parameters in long bones and vertebrae. This results in inferior mechanical performance of the entire bone with a high fracture risk. RNA sequence analysis of the growth plates demonstrated an imbalance in extracellular matrix formation and degradation and impairment of proliferation, differentiation and mineralization processes. Our findings highlight, for the first time, the severe impact of consuming ultra-processed foods on the growing skeleton. This pathology extends far beyond that explained by the known metabolic effects, highlighting bone as a new target for studies of modern diets. Bone Research (2021) ;9:14 https://doi.org/10.1038/s41413-020-00127-9 1234567890();,: INTRODUCTION penetration of blood vessels and bone tissue formation by The vertebrate skeleton has evolved as a dynamic system that osteoblasts.1,2,4,6 The EO process is tightly orchestrated by various serves numerous functions, such as protecting internal organs, signaling molecules and transcription factors, including transform- creating attachment sites for muscles to produce locomotion, ing growth factor β/bone morphogenetic protein (BMP), fibroblast providing a reservoir for minerals, and serving as a hematopoietic growth factor (FGF), Wnt, hedgehog, and the transcription factor niche.
    [Show full text]
  • Regulation of Aggrecanases from the Adamts Family and Aggrecan Neoepitope Formation During in Vitro Chondrogenesis of Human Mesenchymal Stem Cells S
    EuropeanS Boeuf et Cells al. and Materials Vol. 23 2012 (pages 320-332) DOI: 10.22203/eCM.v023a25 Aggrecanases in chondrogenesis ISSN 1473-2262of MSCs REGULATION OF AGGRECANASES FROM THE ADAMTS FAMILY AND AGGRECAN NEOEPITOPE FORMATION DURING IN VITRO CHONDROGENESIS OF HUMAN MESENCHYMAL STEM CELLS S. Boeuf1, F. Graf1, J. Fischer1, B. Moradi1, C. B. Little2 and W. Richter1* 1 Research Centre for Experimental Orthopaedics, Orthopaedic University Hospital, Heidelberg, Germany 2 Raymond Purves Bone and Joint Research Laboratories, Kolling Institute of Medical Research, University of Sydney at The Royal North Shore Hospital, Sydney, Australia Abstract Introduction Aggrecanases from the ADAMTS (A Disintegrin And Chondrogenesis is a process engaging differentiating cells Metalloproteinase with ThromboSpondin motifs) family into production of a large amount of extracellular matrix are important therapeutic targets due to their essential which fi lls the growing distance between them. This role in aggrecan depletion in arthritic diseases. Whether matrix is mainly composed of a network of collagen type their function is also important for matrix rearrangements II fi brils and of proteoglycans, among which aggrecan during chondrogenesis and thus, cartilage regeneration, is predominant. Matrix homeostasis is ensured as is however so far unknown. The aim of this study was to chondrocytic cells synthesise matrix degrading enzymes analyse the expression and function of ADAMTS with such as matrix metalloproteases (MMPs) and enzymes aggrecanase activity during chondrogenic differentiation from the “A Disintegrin And Metalloproteinase with of human mesenchymal stem cells (MSCs). Chondrogenic ThromboSpondin motifs” protein family (ADAMTS). differentiation was induced in bone marrow-derived MSC Matrix rearrangements by cleavage of collagen fi brils pellets and expression of COL2A1, aggrecan, ADAMTS1, or aggrecan are expected to be particularly important 4, 5, 9, 16 and furin was followed by quantitative RT- during chondrogenesis, when the extracellular space PCR.
    [Show full text]
  • Fibroblasts from the Human Skin Dermo-Hypodermal Junction Are
    cells Article Fibroblasts from the Human Skin Dermo-Hypodermal Junction are Distinct from Dermal Papillary and Reticular Fibroblasts and from Mesenchymal Stem Cells and Exhibit a Specific Molecular Profile Related to Extracellular Matrix Organization and Modeling Valérie Haydont 1,*, Véronique Neiveyans 1, Philippe Perez 1, Élodie Busson 2, 2 1, 3,4,5,6, , Jean-Jacques Lataillade , Daniel Asselineau y and Nicolas O. Fortunel y * 1 Advanced Research, L’Oréal Research and Innovation, 93600 Aulnay-sous-Bois, France; [email protected] (V.N.); [email protected] (P.P.); [email protected] (D.A.) 2 Department of Medical and Surgical Assistance to the Armed Forces, French Forces Biomedical Research Institute (IRBA), 91223 CEDEX Brétigny sur Orge, France; [email protected] (É.B.); [email protected] (J.-J.L.) 3 Laboratoire de Génomique et Radiobiologie de la Kératinopoïèse, Institut de Biologie François Jacob, CEA/DRF/IRCM, 91000 Evry, France 4 INSERM U967, 92260 Fontenay-aux-Roses, France 5 Université Paris-Diderot, 75013 Paris 7, France 6 Université Paris-Saclay, 78140 Paris 11, France * Correspondence: [email protected] (V.H.); [email protected] (N.O.F.); Tel.: +33-1-48-68-96-00 (V.H.); +33-1-60-87-34-92 or +33-1-60-87-34-98 (N.O.F.) These authors contributed equally to the work. y Received: 15 December 2019; Accepted: 24 January 2020; Published: 5 February 2020 Abstract: Human skin dermis contains fibroblast subpopulations in which characterization is crucial due to their roles in extracellular matrix (ECM) biology.
    [Show full text]
  • Identification, by Systematic RNA Sequencing, of Novel Candidate
    Laboratory Investigation (2015) 95, 1077–1088 © 2015 USCAP, Inc All rights reserved 0023-6837/15 Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors Anne E Sarver1, Aaron L Sarver2, Venugopal Thayanithy1 and Subbaya Subramanian1 Human sarcomas comprise a heterogeneous group of more than 50 subtypes broadly classified into two groups: bone and soft tissue sarcomas. Such heterogeneity and their relative rarity have made them challenging targets for classification, biomarker identification, and development of improved treatment strategies. In this study, we used RNA sequencing to analyze 35 primary human tissue samples representing 13 different sarcoma subtypes, along with benign schwannoma, and normal bone and muscle tissues. For each sarcoma subtype, we detected unique messenger RNA (mRNA) expression signatures, which we further subjected to bioinformatic functional analysis, upstream regulatory analysis, and microRNA (miRNA) targeting analysis. We found that, for each sarcoma subtype, significantly upregulated genes and their deduced upstream regulators included not only previously implicated known players but also novel candidates not previously reported to be associated with sarcoma. For example, the schwannoma samples were characterized by high expression of not only the known associated proteins GFAP and GAP43 but also the novel player GJB6. Further, when we integrated our expression profiles with miRNA expression data from each sarcoma subtype, we were able to deduce potential key miRNA–gene regulator relationships for each. In the Ewing’s sarcoma and fibromatosis samples, two sarcomas where miR-182-5p is significantly downregulated, multiple predicted targets were significantly upregulated, including HMCN1, NKX2-2, SCNN1G, and SOX2.
    [Show full text]
  • ADAM8 in Squamous Cell Carcinoma of the Head and Neck
    Zielinski et al. BMC Cancer 2012, 12:76 http://www.biomedcentral.com/1471-2407/12/76 RESEARCH ARTICLE Open Access ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study Valerie Zielinski1, Markus Brunner1, Gregor Heiduschka1, Sven Schneider1, Rudolf Seemann2, Boban Erovic1 and Dietmar Thurnher1,3* Abstract Background: A disintegrin and metalloproteinase (ADAMs) have been associated with multiple malignancies. ADAMs are involved in cell fusion, cell migration, membrane protein shedding and proteolysis. ADAM8 has been found to be overexpressed in squamous cell carcinomas of the lung. A new study showed that ADAM8 is significantly overexpressed in metastasis of squamous cell carcinomas of the head and neck (HNSCC). Methods: We determined ADAM8 levels in the serum of 79 HNSCC patients at the time of diagnosis, in 35 patients 3 months after treatment and in 10 patients 1 year after therapy and compared the results to the sera of 31 healthy volunteers. We also constructed tissue microarrays to detect ADAM8 immunohistochemically in 100 patients. The results were correlated with the survival data of the patients to determine the diagnostic and prognostic value. Results: The data demonstrated that patients with high ADAM8 expression in the tumor have worse survival rates. We found that high ADAM8 serum levels correlated with high ADAM8 expression in tumor samples. Soluble ADAM8 levels did not show any prognostic or diagnostic properties. Conclusion: In summary ADAM8 expression is a prognostic factor for survival of patients with head and neck squamous cell carcinoma. Keywords: ADAM8, Squamous cell carcinoma, Head and neck Background family of snake venomases. These reprolysin families Worldwide more than half a million patients are diag- share the metalloproteinase domain with matrix metal- nosed with HNSCC [1].
    [Show full text]